61 results
SC TO-T/A
EX-99
Corerx Inc
8 Apr 24
Third party tender offer statement (amended)
10:58am
advisor to Societal CDMO.
About CoreRx
CoreRx, Inc. is an industry leading CDMO, providing innovative drug formulation, development, and GMP
10-K/A
2023 FY
SCTL
Societal CDMO Inc
5 Apr 24
Annual report (amended)
4:14pm
Committee and was a member of the Executive Committee. Mr. Churchill is a director of Innovative Solutions and Support, Inc., Amkor Technology, Inc … strategy. Mr. Arens graduated from Purdue University with a B.S. in financial planning.
Mr. Arens’ extensive financial experience investing in innovative
SC14D9C
EX-99.2
SCTL
Societal CDMO Inc
29 Feb 24
Written communication relating to third party tender offer
5:18pm
expertise, innovative technologies, and collaborative relationships. Aligned Missions, Visions and Values - A Great Start!!
Principles & Values – Synergistic
8-K
EX-99.2
SCTL
Societal CDMO Inc
28 Feb 24
Form of Tender and Support Agreement
4:58pm
CDMO, providing innovative drug formulation, development, and GMP manufacturing to global pharmaceutical and biotech partners. CoreRx operates from two
8-K
EX-99.1
SCTL
Societal CDMO Inc
8 Nov 23
Societal CDMO Reports Third Quarter 2023 Financial Results
4:11pm
as the growing number of ongoing and planned clinical trials in this area. We are very excited to be working in this innovative area of drug
8-K
xtl84ugb 0b36a9
23 Aug 23
Departure of Directors or Certain Officers
4:13pm
8-K
EX-99.1
rxe2 fxfctwwl
10 Aug 22
Societal CDMO Reports Second Quarter 2022 Financial Results
4:13pm
8-K
EX-99.1
v2f1sbasr38
5 May 22
Societal Cdmo Signs Three-year Manufacturing and Supply Agreement with Infectopharm for Ritalin La® In Europe
7:05am
8-K
EX-99.1
jcesp rb73v7by1m1
9 Aug 21
Recro Reports Second Quarter 2021 Financial Results
4:12pm
424B5
dy3iy8g3sz h8b66kj
13 May 21
Prospectus supplement for primary offering
12:00am
424B5
1l29q8d
11 May 21
Prospectus supplement for primary offering
5:29pm
PRE 14A
sdxixyf3vdds3ji5
15 Mar 21
Preliminary proxy
9:00am
424B5
3thudxp
26 Feb 21
Prospectus supplement for primary offering
5:30pm
424B5
obkvt54lsteob
10 Aug 20
Prospectus supplement for primary offering
8:00am